Phase II Pilot Study of Cyclophosphamide and Active Intralymphatic Immunotherapy
Phase II Pilot Study of Cyclophosphamide and Active Intralymphatic
Immunotherapy With a Vaccine Containing Interferon alfa or Interferon gamma-Treated
Tumor Cells Followed by Sargramostim (GM-CSF) in Patients With Advanced Cancers
Background:
Drugs used in chemotherapy use different ways to stop tumor cells from dividing
so they stop growing or die. Vaccines made from a patient's tumor tissue may
make the body build an immune response to kill tumor cells. Chemotherapy combined
with vaccine therapy may kill more tumor cells. This is a Phase II trial to study
the effectiveness of cyclophosphamide plus tumor cell vaccine in treating patients
who have metastatic cancer or cancer at high risk of recurrence.
Location/Contacts:
California
Los Angeles
St. Vincent Medical Center - Los Angeles
Charles L. Wiseman, MD, FACP, Protocal Chair
Ph: 213-484-7575
